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(À0.9 s.d.), respectively. The proband exhibited hypertelorism, microcephaly and synophrys (Figure 1c) . At 28 years, magnetic resonance imaging (MRI) showed cerebral atrophy, cerebellar atrophy and a thin corpus callosum (Figure 1d ). He could walk and communicate until he was 14 years old, but became unable to do either of this after developing epilepsy. At the age of 4 years and 10 months, his total Developmental Quotient was 22, calculated by using the Kyoto Scale of Psychological Development. A blood investigation showed that his IgA level was low. The HbH inclusion body that is detected frequently in patients with ATRX mutation was not found by brilliant cresyl staining. His younger brother (III-2) had intrapartum asphyxia and two maternal uncles (II-3, II-4) died immediately after birth.
The cousin of the proband (III-3) was born in 41 weeks after an uneventful pregnancy to non-consanguineous healthy parents by normal delivery. At birth, his weight and OFC were 2850 g (À1.2 s.d.) and 37 cm (+2.4 s.d.), respectively. He was characterized by macrocephaly. He had started smiling at 2-3 months, holding up his head at 4 months, sitting by himself at 12 months and walking at 40 months. At 32 years of age, his height, weight and OFC were in the normal range (164.5 cm, À1.1 s.d.; 57 kg, À0.5 s.d.; 59.4 cm, +1.8 s.d.). Information on his Developmental Quotient was unavailable. A blood investigation showed that his IgA level was low. He had been affected Figure 1 (a) Profile of the copy-number ratio on chromosome X in the proband (III-1) detected with aCGH using an MCG X-tiling array. Each dot represents the test/ reference value after normalization and log 2 transformation in each BAC clone, and arrows indicate duplications (ratio40.4). The gray vertical lines represent the centromeric region for which no clones were available. Arrowheads indicate benign CNVs (Supplementary Table 1 Table 1 ) and in part in our CNV database (MCG CGH database, http://www.cghtmd.jp/CNVdatabase). Subsequent real-time quantitative genomic PCR (qPCR) using primer sets recognizing around dup(X)(q21.1) (Supplementary Table 2 ) narrowed down dup(X)(q21.1) to between positions 76646868 and 76973049, including all of ATRX and part of MAGT1 (Figure 1d ). Fluorescence in situ hybridization (FISH) detected these duplications in the proband's unaffected mother (II-2) and his affected maternal male cousin (III-3) (Figures 1b and f) , indicating maternally inherited duplications in these patients. In addition, the duplicated segment at Xq21.1 inserted into the duplicated region at Xq28, by contrast the segment at Xq28 was duplicated in tandem ( Figure 1f ). Our finding that the mother, a presumptive obligate carrier, had completely skewed X inactivation (dup(X):X¼50:0) in a lymphoblastoid cell line , as shown by the androgen receptor X-inactivation assay described previously 5 and a late replication assay 6 with FISH ( Supplementary Figure 1) , supported our assumption that skewed X-chromosome inactivation appears to be characteristic of carriers of MECP2 duplication such as other reported cases. 3 The two affected men showed severe MR, muscular hypotonia, recurrent respiratory infections and various other features characteristic of MECP2 duplication syndrome (Table 1) . Moreover, they did not show short stature, hypoplastic genitalia and early life feeding issues, which were reported to be characteristic of MR in patients with duplications encompassing ATRX (Table 1) . 9 The smallest region of overlap (SRO) of the reported ATRX duplication cases contains 11 genes, including ATRX and two miRNAs, 9 whereas the duplicated region of the present family includes only ATRX (Figure 1e ), suggesting that genes other than ATRX within the SRO contribute to phenotypes observed in previously reported cases (Table 1) . 9 ATRX interacts with MECP2 in vitro and colocalizes at pericentromeric heterochromatin in mature neurons of the mouse brain. 10 Recently, it was reported that ATRX, MECP2 and cohesin cooperate to silence a subset of imprinted genes in the postnatal mouse brain. 11 Those experimental findings suggest that abnormally expressed ATRX with MECP2 through their simultaneous duplications may modify the phenotypes usually observed in MECP2 duplication syndrome. Although our patients showed neither notably different nor more severe phenotypes compared with reported patients with MECP2 duplication syndrome, the proband was found to have cerebellar atrophy by MRI (Figure 1e ), which has never been reported before in MECP2 duplication syndrome. 1,3 It is possible that these phenotypes in the proband were modified through ATRX duplication in an additive or epistatic manner.
The mutations in ATRX give rise to changes in the pattern of methylation of several highly repeated sequences, including the ribosomal DNA (rDNA) arrays 12 and significantly altered mRNA expression in four ATRX targets (NME4, SLC7A5, RASA3 and GAS8) relative to normal controls. 13 Although a Southern blot hybridization method reported previously 12 showed no change in the pattern of methylation at rDNA arrays compared with normal controls (Figure 2a) , quantitative RT-PCR revealed that the expression of ATRX was upregulated in the present cases. Although SLC7A5 expression showed no previous change compared with that in the healthy control (Figure 2b ) and the expression of GAS8 was too low for quantitative RT-PCR (data not shown), the expression of NME4 and RASA3 was similar to that in the patients with ATRX mutations. The alteration to the expression may be influenced by MECP2 duplication or additive/epistatic effect between ATRX and MECP2 duplication. The result of FISH suggests that ATRX duplication and MECP2 duplication were occurred simultaneously resulting in complex genomic rearrangement. The proximal breakpoint of dup(X)(q21.1) and distal breakpoint of dup(X)(q28) were located on segmental duplications (Figure 1e ) and the duplicated sequence at Xq21.1 existed near dup(X)(q28) (Figure 1f ). Fork Stalling and Template Switching (FoSTeS) has been proposed as a replication-based mechanism that produces nonrecurrent rearrangements potentially facilitated by the presence of segmental duplications. 14 Previous reports suggested that complex genomic rearrangements at Xq28 such as an embedded triplicated segment and stretches of non-duplicated sequence within dup(X)(q28) were probably mediated by FoSTeS, 7, 15 and a particular genomic architecture, especially low copy repeats at distal breakpoints of dup(X)(q28), may render the MECP2 region unstable. Thus, the dup(X)(q28) and dup(X)(q21.1) detected in our patients might be generated simultaneously by FoSTeS or other mechanism in a segmental duplication-dependent manner, suggesting the structural analysis of the entire X chromosome in patients with dup(X)(q28) to be important for understanding their correct clinical condition and providing appropriate education. Table 3 ). DNA samples were digested with PstI followed by the methylation-sensitive enzyme EcoRI. Hybridization is shown for probes corresponding to the region between restriction sites of the two enzymes in the 3¢ end of the non-transcribed spacer. The methylated, uncut band is indicated (arrow). A restriction map of part of the rDNA repeat unit shown with the 18S, 5.8S and 28S genes in order and transcribed spacer as filled and open boxes, respectively, represents the sites for PstI (P) and EcoRI (E). A black bar indicates the probe for the Southern hybridization. The size of the DNA segment resulting from the restriction enzymes is represented by closed arrows. (b) Real-time quantitative RT-PCR analysis of the mRNA expression of ATRX and three ATRX target genes (NME4, RASA3 and SLC7A5) but not GAS8, the expression of which was too low to be estimated, in lymphoblastoid cells of our two patients, ATR-X patients whose ATRX mutations were identified through routine screening in a set of known XLMR genes by the Japanese Mental Retardation Consortium (unpublished data, n¼5; Supplementary Table 3) and controls, including six healthy samples, the proband's parents, and a patient and a carrier with the MECP2 duplication. 2 All the subjects provided written informed consent for the use of their phenotypic and genetic data. The proband's carrier mother, the patient and the carrier with the MECP2 duplication are represented by a cross, triangle and square, respectively, in the control column. Data show the average values for fold differences relative to a normal male. Black bars represent mean values of each group.
